Abstract
The strict mathematical relationship between Rt and the curve of daily cases f(t) is shown. Up-to-date and statistically robust Rt from the curve of daily cases can be estimated as soon as new cases are added to the curve. That is equivalent to estimating Rt by averaging all detected cases of infection, without any distortion induced by the difficulty of following and weighting trees of secondary cases from original ones, and without needing to wait for secondary cases to manifest infection. With this method, if Rt scaled numbers are of interest, only the average duration of infectivity of subjects has to be estimated directly, but independently of linking secondary cases to primary ones. A new index, instantaneous reproduction number Rist is introduced, which does not depend on the duration of infectivity of subjects. Rist, Rt and the doubling/halving time of the epidemics may be estimated by simple computations at the very detection time of new daily cases. Any smoothed curve of daily cases gives smooth Rt and Rist. No phase lag on Rt estimate is introduced by this method.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The study uses public data and does not refer to clinical trials
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is about mathematical methods. The epidemic data used are official data and of public domain.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos